Last reviewed · How we verify

NCT07375095

A Study of a Sleep Supplement to Improve Sleep in Women Going Through Menopause

Completed NA Last updated 29 January 2026
What this trial tests

NA trial testing Sleep Supplement in Sleep Disturbance in 128 participants. Completed in 7 April 2024.

Timeline
10 October 2023
Primary endpoint
7 April 2024
7 April 2024

Quick facts

Lead sponsorBonafide Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment128
Start date10 October 2023
Primary completion7 April 2024
Estimated completion7 April 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Bonafide Health — full company profile →

Who can join

Adults 40 to 65, female only, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated whether a daily dietary sleep supplement could improve sleep in women aged 40 to 65 who experience moderate sleep disturbances during menopause. Participants were randomly assigned to take either the supplement or a placebo for about three weeks. All study visits were conducted virtually. Sleep was assessed through daily diaries and weekly questionnaires measuring sleep quality, nighttime awakenings, daytime alertness, and mood. The study's goal was to compare changes between the supplement and placebo groups and to assess safety and tolerability during the study period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sleep Supplement

Trials testing the same drug.

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

Other Bonafide Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07375095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing